Shareholders’ equity

9 Months Ended

Apr. 30, 2025

Equity [Abstract]

Shareholders’ equity

Stockholders’ equity

The following table presents a summary of the Company’s share activity:

	Three months ended		Nine months ended
	April 30,		April 30,
	2025	2024	2025	2024
Ordinary shares:
Balance at beginning of period	—	232,171,182	232,171,182	232,171,182
Treasury shares canceled	—	—	(30,827,929)	—
Ordinary shares canceled	—	—	(201,343,253)	—
Balance at end of period	—	232,171,182	—	232,171,182
Common stock:
Balance at beginning of period	201,343,253	—	—	—
Common stock issued	—	—	201,343,253	—
Balance at end of period	201,343,253	—	201,343,253	—
Treasury shares:
Balance at beginning of period	(2,312,552)	(29,168,420)	(30,827,929)	(27,893,680)
Treasury shares canceled	—	—	30,827,929	—
Share repurchases	(1,550,783)	(827,205)	(4,118,174)	(2,319,358)
Treasury shares used to settle share-based compensation awards	8,660	1,851	263,499	219,264
Balance at end of period	(3,854,675)	(29,993,774)	(3,854,675)	(29,993,774)
Employee Benefit Trusts:
Balance at beginning of period	—	—	—	(274,031)
Employee Benefit Trust shares used to settle share-based compensation awards	—	—	—	253,212
Shares sold upon termination of Employee Benefit Trust	—	—	—	20,819
Balance at end of period	—	—	—	—
Total shares outstanding at end of period	197,488,578	202,177,408	197,488,578	202,177,408

Employee Benefit Trusts

Two Employee Benefit Trusts had been previously established in connection with the Company’s discretionary share award plans and long-term incentive plans. During fiscal 2024, each of these trusts were terminated with all shares disbursed or sold.

Share Repurchases

In March 2025, the Company extended the share repurchase program by an additional $1.0 billion. As such, the Company is purchasing shares under an authorization that allows up to $5.0 billion in share repurchases. As of April 30, 2025, the Company had completed $3.9 billion in share repurchases under the authorized program.

Ordinary Shares and Treasury shares

As of August 1, 2024, the Company canceled all ordinary shares in connection with its completion of the Merger. As a result, in the first quarter of fiscal 2025, 30,827,929 ordinary shares held in treasury were canceled, 201,343,253 of outstanding ordinary shares not held in treasury were canceled and 201,343,253 shares of common stock were issued as consideration therefor.